Clinical trials: Schizo Affective Disorder
Smoking Cessation, Schizophrenia
Examining Persistence in Smokers With Schizophrenia
All participants will receive free weekly counseling (8- weeks) and free nicotine patches (10-weeks). They will complete assessment measures commonly used in smoking cessation studies.
- Conditions
- Smoking Cessation, Schizophrenia, Schizo Affective Disorder
- Trial name
- NCT03346291
- Testing
- counseling
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- Rutgers, The State University of New Jersey
Schizophrenia, Schizo-affective Disorder
Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia
To evaluate the safety and tolerability of multiple doses of PF-02545920 subjects with schizophrenia or schizo-affective disorder who are currently clinically stable and to evaluate the serum and urine pharmacokinetics of…
- Trial name
- NCT00463372
- Testing
- PF-02545920
- Where
- South Africa
- Volunteers
- 40 people
- Sponsor
- Pfizer
Schizophrenia, Schizo Affective Disorder
Mobile Enhancement of Motivation in Schizophrenia
Motivation deficits are a strong determinant of poor functional outcomes in people with schizophrenia. Mobile interventions are a promising approach to improving these deficits, as they can provide frequent cues and…
- Conditions
- Schizophrenia, Schizo Affective Disorder, Psychosis
- Trial name
- NCT03059771
- Testing
- Mobile Enhancement of Motivation (MEMS), Control
- Where
- United States
- Volunteers
- 59 people
- Sponsor
- Indiana University
Schizophrenia Relapse, Schizophrenia
Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse
About 1 in 100 people will experience an episode of psychosis. Some people will only experience one 'psychotic episode' and about a quarter of people make a full recovery.
- Conditions
- Schizophrenia Relapse, Schizophrenia, Schizo Affective Disorder, Psychotic Disorders
- Trial name
- ExPRESS:2 (NCT03558529)
- Volunteers
- 27 people
- Sponsor
- Manchester Academic Health Science Centre
Schizophrenia, Schizo-affective Disorder
A Shared Decision-making Training for Inpatients With Schizophrenia
"Shared decision-making" is being promoted as a promising approach for engaging patients with schizophrenia in medical decisions and improving satisfaction and adherence.
- Trial name
- NCT02349880
- Testing
- shared decision making training
- Volunteers
- 264 people
- Sponsor
- Technical University of Munich
Schizophrenia, Schizo-Affective Disorder
Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels
The importance of stress as a possible deteriorating factor for schizophrenic patients is well documented. However, this notion is based on subjective experience and retrospective psychological analysis.
- Trial name
- NCT01754532
- Testing
- Hair Sample
- Where
- Israel
- Volunteers
- 34 people
- Sponsor
- Shalvata Mental Health Center
Schizo-affective Disorder, Bipolar Disorder
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
The purpose of this study is to assess the efficacy of oral glycine as an augmentation strategy in two psychotic patients with a triplication (4 copies) of the gene glycine decarboxylase (GLDC).
- Trial name
- NCT01720316
- Testing
- Glycine
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- Mclean Hospital
Schizophrenia, Schizo Affective Disorder
Financial Incentives to Improve Acceptance of Antipsychotic Injections
There is a lack of incentive approach for patients who suffer from schizophrenia yet lack the insight to accept treatment. Most existing approaches involve coercion and involuntary hospitalizations.
- Conditions
- Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder
- Trial name
- NCT03192631
- Testing
- Financial incentive
- Volunteers
- 20 people
- Sponsor
- Focus Community Mental Health Team
Schizophrenia, Schizo-affective Disorder
Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients
Patients who suffer from diseases of the schizophrenia spectrum are frequently burdened by weight gain. Sport programs have been shown to improve somatic and psychological health.
- Trial name
- NCT01547026
- Testing
- Implementation Intentions
- Where
- Germany
- Volunteers
- 42 people
- Sponsor
- University of Konstanz
Psychosis, Schizophrenia
Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis
This research investigates a new talking therapy aimed at helping people to come to terms with the experience of psychosis. The new therapy is called Acceptance and Commitment Therapy for psychosis (PACT).
- Conditions
- Psychosis, Schizophrenia, Bipolar Disorder, Schizo-affective Disorder
- Trial name
- PACT (NCT01003132)
- Testing
- Acceptance and Commitment Therapy
- Where
- United Kingdom
- Volunteers
- 27 people
- Sponsor
- University of Glasgow